Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wraith JE et al. – Findings demonstrated clinically relevant beneficial effects of miglustat on neurological disease progression in adult, juvenile and pediatric patients with NP–C, particularly those diagnosed in late childhood and in juveniles and adults, compared with those diagnosed in early childhood. With the approval of miglustat, treatment of patients with NP–C can now be aimed toward stabilizing neurological disease, which is likely the best attainable therapeutic goal for this disorder.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address